BofA/Merrill Lynch Downgrades ResMed (RMD) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Citi Upgrades ResMed (RMD) to Buy
August 2, 2017 6:43 AM EDTCiti upgraded ResMed (NYSE: RMD) from Neutral to Buy.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $77.48 yesterday.
... MoreResMed (RMD) Tops Q4 EPS by 2c, Beats on Revenues
August 1, 2017 4:14 PM EDTResMed (NYSE: RMD) reported Q4 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $556.7 million versus the consensus estimate of $555.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
... More